Immunoprophylactic Potential of a Cocktail of Three Low Molecular Weight Antigens of Leishmania donovani along with Various Adjuvants Against Experimental Visceral leishmaniasis

BACKGROUND: Currently, there is no vaccine available for any form of leishmaniasis for human use, including visceral leishmaniasis (VL). The treatment relies on drugs associated with severe toxic side effects and increased parasite drug resistance. At present, there is a strong need to develop and i...

Descripción completa

Detalles Bibliográficos
Autores principales: KAUR, Harpreet, THAKUR, Ankita, KAUR, Sukhbir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019588/
https://www.ncbi.nlm.nih.gov/pubmed/29963081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019588/
https://www.ncbi.nlm.nih.gov/pubmed/29963081

Ejemplares similares